Anika Therapeutics, Inc.: accounts_payable
| Value | {"amount": 1201000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2014-12-31) |
| Status | current |
| Entity | Anika Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1b3a358f-8c41-4c93-a04d-766daf5d7a8a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001171843-16-008487Retrieved: 2026-08-19T09:02:49.639345+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000898437/accounts-payable/2014-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1b3a358f-8c41-4c93-a04d-766daf5d7a8a
History
- supersedes {"amount": 1201226, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001171843-15-001395)